✦ LIBER ✦

Re: The Clinical Features and Management of Testicular Germ Cell Tumours in Patients Aged 60 Years and Older

✍ Scribed by Richie, Jerome P.

Book ID: 119308192
Publisher: Lippincott Williams and Wilkins
Year: 2012
Tongue: English
Weight: 106 KB
Volume: 188
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2012.06.087

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Re: The Clinical Features and Management

Re: The Clinical Features and Management of Testicular Germ Cell Tumours in Patients Aged 60 Years and Older

✍ Griebling, Tomas L. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 93 KB

THE CLINICAL FEATURES AND MANAGEMENT OF

THE CLINICAL FEATURES AND MANAGEMENT OF TESTICULAR GERM CELL TUMOURS IN PATIENTS AGED 60 YEARS AND OLDER

✍ Daniel M. Berney 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

The clinical features and management of

The clinical features and management of testicular germ cell tumours in patients aged 60 years and older

✍ Matthew J. Wheater; James Manners; Luke Nolan; Peter D. Simmonds; Matthew C. Hay 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB

639 The effect of age on prognosis in ge

639 The effect of age on prognosis in germ cell testicular tumour patients over 40 years old

✍ K. Inci; S. Dogan; S. Keskin; S. Eskicorapci; C. Tasar; S. Kendi; H. Ozen 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 194 KB

CLINICAL USE OF A.F.P. AND H.C.G. IN TES

CLINICAL USE OF A.F.P. AND H.C.G. IN TESTICULAR TUMOURS OF GERM-CELL ORIGIN

✍ Nrgaard-Pedersen, Bent; Albrechtsen, R.; Bagshawe, K.D.; Buffe, D.; Endo, Y.; He 📂 Article 📅 1978 🏛 The Lancet 🌐 English ⚖ 165 KB

Hodgkin disease in patients 60 years of

Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease

✍ Rabia Mir; James Anderson; James Strauchen; Nis I. Nissen; M. Robert Cooper; Sam 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 904 KB

Background. This article reviews the salient pathologic and clinical features of 171 patients with Stage III-IV disease who were 60 years of age or older who were treated on four Hodgkin disease (HD) protocols from 1969 to 1988. Methods. Pretherapy sections were reviewed centrally for correlation o